Marshall Kadin, MD
Professor
Boston University School of Medicine
Dept of Dermatology

MD, Northwestern University



Roger Williams Medical Center


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Kadin ME, Glicksman CA. Commentary on: Breast Implant-Associated Anaplastic Large-Cell Lymphoma in a Transgender Woman. Aesthet Surg J. 2017 Sep 01; 37(8):NP88-NP89. PMID: 29036946.
  2. Kadin ME, Morgan J, Xu H, Glicksman CA. CD30+ T Cells in Late Seroma May Not Be Diagnostic of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Aesthet Surg J. 2017 07 01; 37(7):771-775. PMID: 28402493; DOI: 10.1093/asj/sjw286;.
  3. Perera LP, Zhang M, Nakagawa M, Petrus MN, Maeda M, Kadin ME, Waldmann TA, Perera PY. Chimeric antigen receptor modified T cells that target chemokine receptor CCR4 as a therapeutic modality for T-cell malignancies. Am J Hematol. 2017 Sep; 92(9):892-901. PMID: 28543380.
  4. Wang X, Dasari S, Nowakowski GS, Lazaridis KN, Wieben ED, Kadin ME, Feldman AL, Boddicker RL. Retinoic acid receptor alpha drives cell cycle progression and is associated with increased sensitivity to retinoids in T-cell lymphoma. Oncotarget. 2017 Apr 18; 8(16):26245-26255. PMID: 28412739; DOI: 10.18632/oncotarget.15441;.
  5. Chen J, Zhang Y, Petrus MN, Xiao W, Nicolae A, Raffeld M, Pittaluga S, Bamford RN, Nakagawa M, Ouyang ST, Epstein AL, Kadin ME, Del Mistro A, Woessner R, Jaffe ES, Waldmann TA. Cytokine receptor signaling is required for the survival of ALK- anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations. Proc Natl Acad Sci U S A. 2017 Apr 11; 114(15):3975-3980. PMID: 28356514; DOI: 10.1073/pnas.1700682114;.
  6. Fan P, Nong L, Sun J, Liu X, Kadin ME, Li T, Tu P, Wang Y. Primary cutaneous anaplastic large cell lymphoma with intralymphatic involvement associated with chronic lymphedema. J Cutan Pathol. 2017 Mar 23. PMID: 28337783; DOI: 10.1111/cup.12933;.
  7. Maliniemi P, Laukkanen K, Väkevä L, Dettmer K, Lipsanen T, Jeskanen L, Bessede A, Oefner PJ, Kadin ME, Ranki A. Biological and clinical significance of tryptophan-catabolizing enzymes in cutaneous T-cell lymphomas. Oncoimmunology. 2017; 6(3):e1273310. PMID: 28405495; DOI: 10.1080/2162402X.2016.1273310;.
  8. Wang X, Boddicker RL, Dasari S, Sidhu JS, Kadin ME, Macon WR, Ansell SM, Ketterling RP, Rech KL, Feldman AL. Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping. Hum Pathol. 2017 Jun; 64:19-27. PMID: 28153507; DOI: 10.1016/j.humpath.2017.01.003;.
  9. Watanabe M, Nakano K, Kadin ME, Higashihara M, Watanabe T, Horie R. CD30 Induces Heat Shock Protein 90 and Signal Integration in Classic Hodgkin Lymphoma Cells. Am J Pathol. 2017 Jan; 187(1):163-175. PMID: 27870927; DOI: 10.1016/j.ajpath.2016.09.007;.
  10. Battistella M, Janin A, Jean-Louis F, Collomb C, Leboeuf C, Sicard H, Bonnafous C, Dujardin A, Ram-Wolff C, Kadin ME, Bensussan A, Bagot M, Michel L. KIR3DL2 (CD158k) is a potential therapeutic target in primary cutaneous anaplastic large-cell lymphoma. Br J Dermatol. 2016 Aug; 175(2):325-33. PMID: 27037558; DOI: 10.1111/bjd.14626;.
Showing 10 of 267 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 255 publications over 38 distinct years, with a maximum of 15 publications in 1996

YearPublications
19802
19813
19823
19833
19843
19858
19865
19879
19888
19896
19908
19917
19926
19937
19949
19959
199615
199710
199814
19999
200012
20019
200210
200312
20046
20054
20063
20075
20084
20093
20106
20114
20122
20134
20149
20154
20166
20178
Contact for Mentoring:


25 Buick St
Boston MA 02215
Google Map


Kadin's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department